Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec in Polycythemia Vera
NCT00430066Phase 2Completed
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Feb 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of imatinib in polycythemia vera (PV), sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoint: Reduction of Haematocrit to less than 45% at 12 months. Started Feb 2007; status: completed.
02
Drugs
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT00430066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430066.